Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 130.85 |
| Open | 130.85 |
| Bid | 135.03 x 1200 |
| Ask | 135.90 x 900 |
| Day's range | 126.53 - 136.13 |
| 52-week range | 119.01 - 497.49 |
| Volume | |
| Avg. volume | 6,887,137 |
| Market cap | 54.016B |
| Beta (5Y monthly) | 1.70 |
| PE ratio (TTM) | 3.99 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Better Buy Ahead of FDA Meetings: Moderna vs. Novavax
Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) both delivered major returns for investors in the early days of the coronavirus vaccine race. Moderna's vaccine entered the market in December of 2020. Novavax's vaccine began winning authorizations a year later -- but isn't yet approved in the United States.
- Motley Fool
4 Nasdaq 100 Stocks Billionaires Piled Into During the First Quarter
Successful money managers used the Nasdaq bear market as a catalyst to buy into these high-growth stocks.
- Zacks
AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot
AstraZeneca's (AZN) third/booster dose of its COVID-19 vaccine gets authorized in Europe for use in adults, both for homologous and heterologous use.
© 2022 Yahoo. All rights reserved.
